CST: 26/05/2016 13:14:45   

And So It Grows... European Pharmaceutical-Biotech Industry Investing Billions in Capital Construction Projects, an Industrial Info News Alert

64 Days ago

SUGAR LAND, TX--(Marketwired - Mar 23, 2016) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the North American Pharmaceutical-Biotech Industry, which includes coverage of pharmaceuticals, biologicals, medical devices and cosmetics, continues to return a healthy capital expenditures (capex) investment profile, Europe's volume of project activity cannot be ignored. Barely months into the launch of the expansion of project coverage into Europe, over $14.5 billion in active capital and maintenance (MRO) activity across the pond has been identified and reported upon.

Within this article: Description of Pharma-Biotech Development in Europe.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Contact:
Brian Ford
(713) 980-9393